Using Mindful Self-Compassion to Improve Self-Criticism, Self-Soothing, Cravings, and Relapse in Substance Abusers in an Intensive Outpatient Program by Gilbert, Sarah Elizabeth
University of Tennessee, Knoxville 
TRACE: Tennessee Research and Creative 
Exchange 
Doctoral Dissertations Graduate School 
12-2014 
Using Mindful Self-Compassion to Improve Self-Criticism, Self-
Soothing, Cravings, and Relapse in Substance Abusers in an 
Intensive Outpatient Program 
Sarah Elizabeth Gilbert 
University of Tennessee - Knoxville, sgilber6@vols.utk.edu 
Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss 
 Part of the Clinical Psychology Commons 
Recommended Citation 
Gilbert, Sarah Elizabeth, "Using Mindful Self-Compassion to Improve Self-Criticism, Self-Soothing, 
Cravings, and Relapse in Substance Abusers in an Intensive Outpatient Program. " PhD diss., University of 
Tennessee, 2014. 
https://trace.tennessee.edu/utk_graddiss/3128 
This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee 
Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized 
administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact 
trace@utk.edu. 
To the Graduate Council: 
I am submitting herewith a dissertation written by Sarah Elizabeth Gilbert entitled "Using Mindful 
Self-Compassion to Improve Self-Criticism, Self-Soothing, Cravings, and Relapse in Substance 
Abusers in an Intensive Outpatient Program." I have examined the final electronic copy of this 
dissertation for form and content and recommend that it be accepted in partial fulfillment of the 
requirements for the degree of Doctor of Philosophy, with a major in Psychology. 
Kristina C. Gordon, Major Professor 
We have read this dissertation and recommend its acceptance: 
Greg Stuart, Todd M. Moore, David Patterson 
Accepted for the Council: 
Carolyn R. Hodges 
Vice Provost and Dean of the Graduate School 
(Original signatures are on file with official student records.) 
 
 
Using Mindful Self-Compassion to Improve Self-Criticism, Self-Soothing, Cravings, and 






A Dissertation Presented for the 
Doctor of Philosophy  
Degree   





























Copyright © 2014 







This dissertation is dedicated to one particular self-compassion group study participant, 
who after maintaining sobriety during and after the study completion, fell victim to random street 
violence and lost his life two months after finishing this study. Those with whom you interacted 







This dissertation would not have been possible without the unyielding love and support I 
received from my parents. Their passion for life and respective careers allowed me to strive to 
create a professional and personal life full of meaning. I will never be able to adequately 
articulate my deep appreciation to them, but I hope they know that I am forever indebted to them 
and aspire to some day find a way to show my gratitude.  
I am equally grateful to Kristina C. Gordon for her mentorship, wisdom, and guidance 
throughout my graduate training. She modeled how one can be a curious and sharp researcher, a 
perceptive and caring clinician, and an effective and inspiring teacher, all while valuing integrity 
above all else. I hope that I never forget that these qualities can coexist in one person and that I 







Applying mindfulness techniques to the treatment of substance use disorders is relatively 
new; however, initial studies show promising results (e.g. Bowen et al., 2009; Witkiewitz & 
Bowen, 2010). Similarly, treatment-seeking substance users may find benefits in treatments that 
increase levels of self-compassion, a construct that uses mindfulness and allows awareness of 
personal faults (e.g. relapses) without becoming paralyzed by shame. Instead, individuals who 
are compassionate toward their failures are more likely to take healthy steps to address them 
(Leary, Tate, Adams, Allen, & Hancock, 2007). This study added a brief self-compassion group 
treatment to an existing Intensive Outpatient Program (IOP) of substance users at a community 
mental health center to explore the potential benefits of increasing self-compassion in this 
population. Overall, 20 persons were recruited for participation in this study; 10 of those 
received the 5-session self-compassion group treatment and 10 were recruited for a treatment as 
usual control. Results found self-compassion to be related to decreased drug use, cravings, 
general psychological symptoms, and an increase in self-soothing behaviors. Additionally, all 
participants experienced a significant reduction in cravings, and those who participated in the 
self-compassion group therapy showed increased and maintained levels of self-compassion and 
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Section 1: Introduction 
 
Alcohol and illicit drug use are significant public health problems, amounting to 5.4% of 
the total burden of disease worldwide (World Health Organization, 2012), and current statistics 
suggest that between 3.4-6.6% of the world’s population aged 15-64 are current drug users 
(United Nations Office on Drugs and Crime, 2012). Whereas substance use disorders prove to be 
a major public health concern requiring economic and social action, perhaps more devastating 
are the personal negative consequences associated with problem alcohol and drug use, including 
car accidents, domestic violence, neurological problems, pregnancy problems, co-morbid 
psychological distress, and even death (Hasin, Stinson, Ogburn, & Grant, 2007).  
 Although individuals who seek treatment for their substance use abstain more than non-
treated individuals (e.g. Tonigan, Toscova, & Miller, 1996), substance use disorders are often a 
chronic problem and multiple relapses are common (Weisner, Matzger, & Kaskutas, 2003). In 
fact, recent research suggests that the relapse rate following substance abuse treatment is over 
60% (McLellan, Lewis, O’Brien, & Kleber, 2000). In order to better understand the high rate of 
relapse, researchers have identified numerous risk factors that appear to be the most influential 
and immediate predictors of post-treatment substance use relapse, including negative affect, 
craving urges, stress, motivation, self-efficacy, and ineffective coping skills (Connors et al., 
1996; Witkiewitz & Marlatt, 2004).  
 Currently, the most commonly used substance use treatment approaches are mutual support 
groups and 12-step programs such as Alcoholics Anonymous (AA) and Narcotics Anonymous 
(NA), which advocate abstinence (Room, 1998). Research suggests that these approaches are 
better than no treatment (Tonigan, Toscova, & Miller, 1996); however, these approaches may not 






morbid psychiatric problems in need of pharmacotherapy (e.g. Zweben & Smith, 1989). Given 
the high comorbidity rates of substance use disorders and other psychiatric disorders, this poses a 
potential problem. As such, recent researchers and practitioners have utilized additional 
treatments for a variety of addictive disorders across diverse populations, many of which address 
the underlying psychological and comorbid disorders as well as the aforementioned risk factors 
related to relapse (e.g. Kadden, 2001; McCrady & Ziedonis, 2001).  
Mindfulness-Based Treatments for Substance Abuse 
 Even more recently, clinicians and researchers have included mindfulness practices in 
substance use treatment programs, either as an adjunct to existing treatments or as a stand-alone 
treatment of substance use disorders (e.g. Bowen, et al., 2009; Witkiewitz, Marlatt, & Walker, 
2005), as substance users tend to have lower levels of mindfulness when compared to normative 
data (Shorey, Brasfield, Anderson, & Stuart, 2014). Mindfulness practice has been described as 
“paying attention in a particular way: on purpose, in the present moment, and non-judgmentally” 
(Kabat-Zinn, 1994, p. 4). This present-focused awareness can be developed through the practice 
of meditation, which is defined as the intentional self-regulation of attention from moment to 
moment (Goleman & Schwartz, 1976). Using mindfulness meditation in the context of therapy or 
group interventions involves teaching individuals several mindfulness meditation techniques 
during which participants are instructed to focus their attention on the target of observation (e.g. 
breathing) and to be aware of it in each present moment (Baer, 2003). According to Kabat-Zinn 
(1982), when participants notice emotions, sensations, or cognitions arising, they are to be 
observed non-judgmentally, and then attention is to be returned to the present moment. The 
theory behind mindfulness meditation in the context of psychotherapy suggests that these 






content (Kabat-Zinn, 1982).  
 Many mindfulness-based clinical interventions exist, including, but not limited to 
Compassionate Mind Training (CMT; Gilbert & Irons, 2005), Dialectical Behavior Therapy 
(DBT; Linehan, Armstrong, Suarez, Allmon, & Heard, 1991), Acceptance and Commitment 
Therapy (ACT; Hayes, Luoma, Bond, Masuda, & Lillis, 2006), and Mindfulness Based Stress 
Reduction and Meditation (MBSR; Kabat-Zinn, 1982). Learning mindfulness meditation 
techniques can be time-consuming. One critique of this type of intervention is that one must be 
proficient in mindfulness meditation in order to use it clinically, yet there is no professional 
credentialing mechanism; however, according to Kabat-Zinn, the feedback from patients seeking 
these treatments tends to be “highly enthusiastic and positive” regardless of the potential training 
challenge (2003). Additionally, critics highlight methodological flaws of many mindfulness-
based treatment studies, including uncontrolled designs, the use of unvalidated measures, and 
inappropriate statistical analyses (Bishop, 2002). Despite these criticisms and potential 
limitations, multiple sources have shown mindfulness-based clinical interventions to be helpful 
in treating a variety of presenting complaints in many different populations, potentially leading 
to improvements in problematic symptoms and experiences, including pain, stress, anxiety, 
depressive relapse, disordered eating, and substance use (e.g. Baer, 2003; Witkiewitz & Bowen, 
2010). Research suggests that mindfulness practices help to reduce negative symptoms by 
allowing participants to safely face and tolerate negative affect, rather than avoiding it or use 
unhealthy coping strategies to manage it (Baer, 2003).   
Furthermore, according to Groves and Farmer (1994), “in the context of addictions, 
mindfulness might mean becoming aware of triggers for craving… and choosing to do 






(p. 189). Theoretically, mindful awareness and acceptance of the constantly changing 
experiences of the present moment allows participants to not immediately give in to cravings, but 
instead “urge surf” (i.e. “ride” the waves of cravings and urges until the wave crests and 
subsides). This leads to the ability to experience pain and negative affect without excessive 
emotional reactivity, which often leads to impulsive behaviors like drinking or using drugs 
(Baer, 2003).  
Integrating mindfulness techniques into the treatment of substance use disorders is 
relatively new; however, as described above, initial studies show promising results. Clinical 
outcome studies have demonstrated that mindfulness practice can aid in addressing substance 
abuse in a variety of ways, including: reducing alcohol and drug use, reducing alcohol related 
problems and psychiatric symptoms (Bowen et al., 2006); decreasing craving and increasing 
acceptance and acting with awareness (Bowen et al., 2009); attenuating the relation between 
depressive symptoms and craving, which was found to be related to less substance use 
(Witkiewitz & Bowen, 2010); and even reducing overall stress levels (Brewer, et al., 2009). One 
treatment in particular has shown promising results: Mindfulness-Based Relapse Prevention 
(MBRP; Witkiewitz, Marlatt, & Walker, 2005), which was designed to directly target negative 
mood, cravings, and their roles in relapse (Witkiewitz & Bowen, 2010). Specifically, Witkiewitz 
and Bowen (2010) found significantly lower rates of substance use and greater decreases in 
cravings when MBRP was offered as an aftercare program following either an inpatient or 
intensive outpatient treatment stay, when compared to post-treatment as usual. 
Self-Compassion and Substance Use 
Recent research is promising for the efficacy of mindfulness-based substance use 






construct of self-compassion. Self-compassion, a concept originating in Buddhism, provides 
positive self-affect in the face of personal suffering or perceived inadequacy that is based on self-
kindness and empathy, a feeling of common humanity, and mindfulness, rather than self-worth 
judgments (Neff, 2003). Theoretically, self-compassion allows awareness of personal faults 
without becoming paralyzed by shame. Instead, individuals who are compassionate toward their 
failures are more likely to take healthy steps to address them (Leary, Tate, Adams, Allen, & 
Hancock, 2007). Self-compassion appears to be uniquely associated with general well-being 
(Neely, Schallert, Mohammed, Roberts & Chen, 2009), compassionate self-soothing (Gilbert & 
Irons, 2004), and to have an inverse relation with shame (Gilbert & Irons, 2005), self-critical 
thoughts and feelings (Gilbert & Irons, 2004), negative self-attributions, rumination, and 
depression (Neff, Kirkpatrick & Rude, 2007), all of which have been linked to problematic 
drinking and drug use. 
Self-compassion is comprised of three bipolar constructs: mindfulness vs. over-
identification, self-kindness vs. self-judgment, and common humanity vs. isolation. As outlined 
above, extensive research has found the presence of mindfulness to be associated with less 
problem alcohol and drug use. Additionally, the common humanity component of self-
compassion may be an important addition to the mindfulness-based conceptualization and 
treatment of substance users, as the effect of recognizing one’s faults and failings as a part of the 
common human experience helps reduce feelings of isolation and break the cycle of self-
absorption associated with substance use (Campbell, 1993). Furthermore, common humanity 
may be important given that group support and the sharing of common struggles between 
substance users is a core principle of many treatments for substance abuse, including Alcoholics 






patients to be more sensitive rather than self-critical of their underlying unpleasant emotional 
states, which may help them to better manage these states, as opposed to using alcohol or drugs 
to numb the inner pain and emotional distress, a common yet maladaptive coping mechanism 
found to be related to substance use and increased relapse rates (Ireland, McMahon, Malow, & 
Kouzekanani, 1994; Potter-Efron, 2002). To assess the effectiveness of self-compassion as a 
predictor of psychological well-being, a recent study found that not only was self-compassion a 
robust predictor of symptom severity and quality of life in anxious and depressed individuals, it 
accounted for more than 10 times the unique variance than mindfulness (Van Damn, Sheppard, 
Forsyth, & Earleywine, 2010). Since substance abuse is highly comorbid with anxiety and 
depressive disorders (as high as 40%; NIDA, 2010), it is possible that self-compassion provides a 
more comprehensive approach to treating substance abuse than simply mindfulness alone.  
To the knowledge of this writer, few previous studies have examined the relation between 
self-compassion and substance use, specifically (e.g., Rendon, 2006; Brooks, Kay-Lambkin, 
Bowman, & Childs, 2012). In an undergraduate sample, Rendon (2006) found a significant 
negative relation between alcohol use and self-compassion. Additionally, a longitudinal study 
examining changes in self-compassion in a treatment seeking sample found the mindfulness 
component to be predictive of less alcohol use over time in men, the self-kindness component to 
be predictive of less alcohol use in older individuals, and the common humanity component to be 
predictive of less alcohol use in women (Gilbert, Shorey, Gordon, & Moore, under review). 
These findings suggest a nuanced approach to understanding the relation between self-
compassion and substance use, suggesting that whereas there may be age and gender differences, 
all three positive components of self-compassion (mindfulness, self-kindness, and common 






Increasing Self-Compassion Therapeutically 
 Over the past decade, researchers and clinicians have examined the effect that self-
compassion focused therapies have on mental health. In a small-scale open clinical trial, Gilbert 
and Proctor (2005) found that CMT, a group treatment developed to help individuals high in 
shame and self-criticism, yielded significant reductions in depression, anxiety, self-criticism, 
shame, inferiority, submissive behavior, and increases in self-soothing and self reassurance. 
Whereas this study was not targeted for substance abusers in particular, it is likely that 
compassion focused treatments would be beneficial for this population, as shame and self-
criticism, and inadequate self-soothing techniques are frequently associated with problem 
substance use and relapse.  
Christopher Germer (2009) also has written about compassion-focused therapy in a self-
help book, The Mindful Path to Self-Compassion: Freeing Yourself from Destructive Thoughts 
and Emotions. In this work, Germer (2009) provides a theoretical rationale for why self-
compassion is so critical and how readers can become more compassionate toward themselves. 
According to Germer (2009), many individuals feel the urge to actively avoid pain; however, he 
argues that absorbing the pain and responding compassionately to imperfections (or relapses) 
without judgments or self-blame may help people to punish themselves less and make steps 
toward healing. Additionally, Germer (2009) suggests that self-compassion is easier when 
patients “give up the struggle” to feel better, stop trying to “fix” their problems/faults/failings, 
and simply start caring for themselves. The principle of “giving up the struggle” may be 
particularly beneficial to a substance using population, as it mirrors the AA/NA theme of the 






experience pain, tolerate it, and respond to it compassionately and without judgment may be 
particularly useful for individuals struggling to overcome addiction. 
 In an accessible and practical way, Germer’s (2009) work guides participants through 
mindfulness exercises to help increase self-kindness, body awareness, tolerance of difficult 
emotions, self-care, and helps troubleshoot when these new techniques become difficult to 
manage. Additionally, he provides exercises to help readers better understand how to best care 
for themselves by helping to identify underlying problematic schemas that may be related to their 
current struggles. Due to the research supporting the use of mindfulness and compassion-focused 
therapies to help treat substance abuse, it is possible that using Germer’s (2009) book as a 
treatment guide could help individuals increase their self-compassion and better manage their 
feelings of stress, inadequacy, and learn to tolerate intense negative emotions while decreasing 
emotional reactivity.  
Current Study 
This study aimed to explore the effectiveness of an adjunct self-compassion treatment for 
substance users enrolled in a community mental health center group Intensive Outpatient 
Program (IOP). The proposed study utilized a repeated case study methodology per the design 
recommendations of recently published repeated case studies of similar nature (e.g. Gilbert & 
Irons, 2004). The five-session self-compassion treatment was based on Germer’s “The Mindful 
Path to Self-Compassion” (2009) and employed Germer’s core principles and activities to teach 
ways to be more self-compassionate during challenging times through the use of mindfulness, 
self-kindness, and common humanity exercises and discussions. The treatment designed was five 






To test the initial efficacy of Germer’s (2009) self-compassion approaches, baseline, post 
treatment, and follow-up assessments tracked participants’ self-compassion, self-criticism, self-
soothing, substance use, cravings, and general symptom severity. Given the preliminary nature of 
this treatment in a substance abusing sample, this study aimed to a) identify whether or not 
individuals receiving this treatment did, in fact, experience increases in self-compassion, b) 
explore the associations and changes throughout treatment between self-compassion, substance 
use and cravings, self-judgment, and compassionate self-soothing, c) evaluate whether 
participants experienced reliable and clinically significant change as a result of treatment and d) 
determined effect sizes to inform the research design of future randomized control studies 
regarding this treatment. In order to control for existing IOP group effects, this study tracked the 
progress of some individuals who did not receive the self-compassion adjunct treatment 
(Treatment As Usual, [TAU]) and effect sizes were compared to determine if the relationship 





It was hypothesized that self-compassion would be negatively associated with self-
judgment, substance use, cravings, and general psychopathological symptoms, and positively 
associated with compassionate self-soothing at baseline, post-treatment, and follow-up.   
Hypothesis 2 
It was hypothesized that self-compassion would increase throughout the self-compassion 
treatment and benefits would be maintained through post and 1-month follow-up assessments. 
                                                 
1
 It should be noted that at the time of this study, there was no published protocol for a mindul 
self-compassion treatment utilizing Germer’s (2009) approaches; however, at the time of this 






Hypothesis 3  
It was hypothesized that self-judgment, substance use, and cravings would decrease and 
compassionate self-soothing would increase during active self-compassion treatment and would 
be maintained through post and 1-month follow-up assessments. 
Hypothesis 4 
It was hypothesized that study participants would exhibit (a) reliable change and (b) 
clinically significant change following participation in the self-compassion treatment on the 
outcome variable of self-compassion, whereas TAU participants would not exhibit reliable 
change or clinically significant change in level of self-compassion. 
Hypothesis 5  
It was hypothesized that effect sizes of self-compassion would be stronger for those 






Section 2: Methods 
Participants 
 Participants were recruited from an 8-week Intensive Outpatient Program (IOP) in an east 
Tennessee community mental health center. The IOP at this center was well established and 
designed to help individuals maintain sobriety following the diagnosis of one or more substance 
use disorders. Group members also attended “aftercare,” a less-involved outpatient program, for 
four additional weeks post IOP completion. The precedent in the literature for exploratory 
repeated case studies of this nature has been approximately 6-10 active treatment participants 
(e.g. Gilbert & Irons, 2004; Gilbert & Proctor, 2006); as such, this study recruited 10 self-
compassion group treatment patients and 10 TAU patients over the course of a 9-month period. 
All IOP participants were 18-years or older and both males and females were eligible to 
participate. Exclusionary criteria included: psychosis, active suicidality, and severe cognitive 
impairment. Patients of all race, ethnicity, age, and living arrangements were eligible. At any 
given time there were approximately 8-15 persons in the rolling-admission IOP group and all 
eligible members were given the opportunity to participate in the study. 
A total of 20 participants were recruited for this study; 10 persons gave informed consent 
to begin the self-compassion group treatment and 10 gave consent to complete questionnaires but 
received no additional treatment outside of the standard IOP protocol (TAU group). There were 
no significant differences in demographics between the treatment and TAU groups. Of the 20 
total participants, 60% identified as male and 40% as female. Participants’ ages ranged from 20-
59, with the average age of participant being 39 in both the self-compassion group treatment and 
TAU group.  With regard to racial demographics, 85% of the participants identified themselves 






household income was between $10,000-$24,999, and only 15% of participants were employed 
at baseline assessment. With regard to retention rates, of the 10 persons who participated in the 
treatment group, 6 finished the self-compassion group and completed post-treatment assessment, 
and 4 returned 1 month later for follow-up assessment. Similar retention rates applied to the 
TAU group; of the 10 persons who completed baseline measures, 7 returned for the post-
assessment, and 4 returned 1-month later for the follow-up assessment.  
Procedure 
 All eligible IOP group members were invited to take part in this collaborative research 
project investigating the importance of self-compassion in substance use related difficulties. This 
study recruited a total of 10 individuals to participate in the self-compassion group treatment. In 
order to collect enough individuals and provide a rich experience for group participants, two 
consecutive groups were recruited and run by trained therapists. There were 6 participants in the 
first self-compassion group, and 4 participants in the second. Both groups were led by the same 
two group leaders and used the same protocol. Once both treatments were completed, 10 
individuals for TAU participation were recruited. Whereas random assignment is typically the 
preferred method for a two-group research design, given the limited access to participants, due to 
the low numbers of IOP patients and the short duration of the program, it was unlikely that the 
active treatment group would have had enough participants to be successful if a random 
assignment methodology was employed.  
 Self-Compassion Treatment Group Protocol 
 When recruiting for the self-compassion treatment group, information about the study and 
the option to participate was offered to group members by the IOP leaders and study coordinator 






treatment participants began attending the weekly self-compassion group during the first three-
weeks of IOP treatment and completed the adjunct self-compassion group treatment by the end 
of the 8-week IOP. Meetings were held during the 1-hour before regularly scheduled IOP 
meetings and were led by two advanced clinical psychology graduate students trained in 
Germer’s (2009) approach to increasing self-compassion. Study participants were asked to not 
speak about the content of the self-compassion group meetings during the regularly scheduled 
IOP meetings to help control for contamination effects. Participants were required to complete 
outcome questionnaires at baseline (week 1), post-treatment (week 8), and 1-month follow-up 
(week 12, during their last week of “aftercare”). All IOP group members were required by group 
therapists to participate in two weekly external substance abuse group meetings (AA/NA), and as 
incentive for participation in the current study, 1-hour of external substance abuse group 
meetings was waved for participants’ attendance in the self-compassion group treatment during 
study treatment weeks. Additionally, participants were compensated $10 in grocery store gift 
cards for completing the first two assessments and $15 in grocery store gift cards for completing 
the follow-up assessment, earning a total of $35 upon study completion. The self-compassion 
group treatment protocol was strictly followed for all participants and no aspects were changed 
or tailored throughout the study.   
 Treatment As Usual (TAU) Protocol 
 When recruiting TAU participants, interested IOP patients were informed of the 
participation requirements at their initial IOP intake meeting or during their first week in IOP. 
TAU requirements included completing questionnaires assessing factors related to self-
compassion and substance use at three time-points throughout the 12-week study. Once potential 






provided consent forms and baseline measures. All participants completed the same measures 
again upon completion of IOP (week 8) and once more 1-month post-treatment (week 12). As 
compensation for their time and efforts, TAU participants were compensated $10 in grocery 
store gifts cards for completing the first two assessments and $15 in grocery store gift cards for 
completing the follow-up assessment, earning a total of $35 upon study completion. 
Measures. 
Demographics 
A general demographic questionnaire was administered asking participants about topics 
including, but not limited to: age, gender, housing arrangements, relationship status, yearly 
income, years of education, and employment status. 
Alcohol Use 
The Alcohol Use Disorders Identification Test (AUDIT; Saunders, Aasland, Babor, De 
La Fuente, & Grant, 1993) is a 10-item self-report measure that assesses quantity and frequency 
of drinking, drinking intensity, symptoms of dependence and tolerance, and alcohol-related 
negative consequences. The AUDIT has high internal consistency and good validity (Saunders, 
Aasland, Amundsen, & Grant, 1993). Scores on the AUDIT are continuous and may range from 
0-40, and a score of 8 or higher is indicative of harmful or hazardous drinking. A recent review 
of the literature indicated that the AUDIT was superior to other alcohol screening instruments 
(Reinert & Allen, 2002).  
Drug Use  
The Drug Use Disorders Identification Test (DUDIT; Stuart, Moore, Kahler, & Ramsey, 
2003; Stuart, Moore, Ramsey, & Kahler, 2003) is a 14-item self-report measure used to screen 






sedatives/hypnotics/anxiolytics, opiates, and “other” substances (e.g. nitrous oxide). The DUDIT 
was modeled after the Alcohol Use Disorders Identification Test (AUDIT; Saunders, Aasland, 
Babor, De La Fuente, & Grant, 1993), and the DUDIT has been employed in previous studies 
with adequate reliability (alpha = .83; Stuart et al., 2003), and high convergent validity (r = .85) 
when compared to the Drug Abuse Screening Test (DAST-10; Skinner, 1982) (Voluse, et al., 
2012).  
Monthly Alcohol and Drug Use 
The Timeline Follow-Back interview (TLFB; Sobell & Sobell, 1996) was used to assess 
substance use at different time points. The TLFB interview is a calendar-assisted structured 
interview, which provides a way to cue memory so that accurate recall is enhanced. The TLFB 
has shown to provide reliable drinking information (Sobell & Sobell, 1996). At baseline, it was 
administered to provide data on the frequency of drug and alcohol use as well as average number 
of standard drinks consumed per day for the 1 month before beginning IOP. The TLFB was also 
used to assess participant’s drug and alcohol at follow-ups, and covered the period since its last 
administration.  
Alcohol and Drug Cravings 
 The Penn Alcohol Craving Scale (PACS; Flannery, Volpicelli, Pettinati, 1999) is a 5-
item self-report measure used to assess frequency and intensity of cravings of alcohol.  The 
PACS is a reliable scale with high convergent reliability with other commonly used alcohol urge 
and cravings questionnaires, and has good predictive validity for relapse (Flannery, Volpicelli, & 
Pettinati, 1999). This same measure has been adapted successfully to measure the frequency and 







Self-Compassion Composite Measure 
The Self-Compassion Scale (SCS; Neff, 2003) is a 26-item self-report questionnaire to 
assess level of self-compassion. The SCS has demonstrated good validity, test-retest reliability, 
and good internal consistency (Neff, 2003). In addition to a total mean score, the SCS has 6 
subscales, assessing three bipolar constructs: self-kindness vs. self-judgment, mindfulness vs. 
over-identification, and common humanity vs. isolation. For this scale, the self-judgment, over-
identification, and isolation subscales are reverse coded so that higher scores indicate higher 
levels of self-compassion.  
Self-Judgment 
The self-judgment subscale of the Self-Compassion Scale (SCS; Neff, 2003) is comprised 
of 5 questions assessing one’s level of self-criticism and judgment (e.g., “when times are really 
difficult, I tend to be tough on myself”). For this scale, higher scores indicate higher levels of 
self-criticism and judgment.  The self-judgment subscale of the SCS was used to assess 
separately for levels of self-criticism, but was not correlated with self-compassion, as it is a 
subscale of the composite self-compassion score. For this study, all 5 questions were added 
together to create one total self-judgment score. 
Self-Soothing 
This study used a 5-item quantitative interval rating scale (0-50) created for use by 
Gilbert and Irons (2004) to assess ease of compassionate self-soothing when faced with a 
challenging situation. High scores on this scale indicate more self-soothing thoughts and 
behaviors, and ratings for self-soothing are given for how easy it was to: self-reassure, self-







General Psychopathology Symptom Assessment 
The Brief Symptom Inventory (BSI; Derogatis & Melisaratos, 1983) is a 53-item self-
report inventory that uses a Likert-scale to assess the extent to which participants have been 
bothered by various symptoms. The BSI has nine subscales designed to assess individual 
symptom groups: somatization, obsessive-compulsive, depression, interpersonal sensitivity, 
anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. The BSI also includes a 
measure of global psychological distress (GSI). The BSI has good reliability (Derogatis & 
Melisaratos, 1983) and research suggests it using this assessment, and the GSI in particular, is an 
appropriate measure of general psychopathology and distress (Skeem, Schubert, Odgers, 






Section 3: Results 
Descriptive Statistics and Correlations 
Descriptive statistics were calculated and all measures were within expected range at 
baseline (Table 1). Initially, to test Hypothesis 1, Pearson Product Moment correlations were 
calculated to assess whether self-compassion was, in fact, negatively associated with substance 
use and cravings, global severity of psychological symptoms (GSI) and positively associated 
with self-soothing behaviors at all time-points
2
. At baseline, the total self-compassion score was 
negatively associated with drug use (r=-.63, p>.01) and GSI (r=-0.71, p<.01), but not alcohol use 
or cravings, nor was it positively associated with self-soothing behaviors (Table 2). At the post-
treatment assessment, self-compassion was negatively associated with drug use (r=-60, p>.05) 
and GSI (r=-0.64, p<.05) and positively associated with self-soothing behaviors (r=.72, p>.01), 
but showed no association with alcohol use or cravings (Table 3). At follow-up assessment, self-
compassion was not significantly associated with either alcohol or drug use; however, it was 
negatively associated with cravings (r=-.90, p>.01) and GSI (r=-0.72, p<.05) and associated with 
more self-soothing behaviors (r=.77, p>.05) (Table 4). In order to test Hypothesis 2, change 
scores were calculated for the 6 persons who completed the self-compassion group treatment, by 
subtracting post-treatment scores from baseline scores for alcohol use, drug use, self-soothing, 
cravings, and GSI, and then correlated with the change scores for self-compassion to explore 
which variables changed most during treatment. Whereas all persons in the self-compassion 
group experienced a reduction in drug and alcohol use and cravings, and an increase in self-
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 The self-compassion composite score and self-judgment score were not correlated, since the 







compassion and self-soothing, the only significant correlation in change scores was with the GSI 
(r=-0.93, p<.01),when compared to the changes in self-compassion (Table 5).  
Treatment Efficacy  
To assess for treatment effectiveness, within subject variance was examined with 
repeated measures analyses of variance at baseline, post-treatment, and 1-month follow-up. If 
significant main effects of time were found with self-compassion, self-soothing, substance use, 
cravings, and GSI, post hoc Bonferroni analyses were calculated to assess when during the study 
the significant changes occurred. Only 6 of the 10 participants completed the treatment, and only 
4 of those 6 completed the 1-month follow-up assessment, resulting in a low number of subjects 
(n=4). According to analyses, a significant main effect of time occurred in cravings between 
post-assessment and follow-up assessment (p<.05) (Table 6), but no significant main effect of 
time occurred on alcohol use, drug use, self-soothing behaviors, total self-compassion, self-
judgment, or GSI. Posthoc analyses were conducted to assess whether time had a main effect on 
any of the other components of self-compassion and none were found to be significant.  
Effect Sizes 
 In order to test hypothesis 5, effect sizes were calculated for all outcome variables in both 
the self-compassion treatment group and TAU to assess whether or not there were measurable 
differences in the size of the changes between baseline and post-treatment and baseline and 
follow-up (Tables 7 and 8).  According to Cohen (1973), effect sizes of .2, .5, and .8 are 
considered small, medium, and large, respectively. In addition to reporting effect sizes (r, which 
is a correlation), Cohen’s d, the mean difference between two groups across time in standard 
deviation units, was calculated by using the following formula [d = M1 – M2/SD] where M1 is 






the pre-assessment. This method, which standardizes the change in functioning based on the 
dispersion of pre-assessment distress scores, is the simplest method for calculating effect sizes 
and is recommended as the “first step” for understanding and measuring clinical change, 
according to Seidel, Miller, and Chow (2013). This statistic is useful when comparing effect 
sizes of two different groups of individuals. Specifically, for the purpose of this study, differing 
effect sizes can be compared to identify and assess which group (e.g., self-compassion group 
treatment or TAU) had a stronger change from baseline to post-treatment. Positive effect sizes 
indicate that the participant reported a lower score at post-assessment (time 2) than at baseline 
assessment (time 1) and negative effect sizes indicate that the participant reported an increased 
score at post-assessment (time 2) than at baseline assessment (time 1) (e.g., positive effect sizes 
for alcohol use indicate a decrease in use over time and negative effect sizes for self-compassion 
indicate an increase in self-compassion over time). 
Self-Compassion Treatment Group 
Small positive effect sizes, in the hypothesized direction, were found between baseline 
and post-treatment for the self-compassion treatment group in the areas of cravings, GSI, and 
number of days drinking and using drugs, as measured by the TLFB. Medium negative effect 
sizes were found between baseline and post-treatment assessments in self-soothing and self-
compassion, indicating an increase in these scores, and medium positive effect sizes were found 
for alcohol and drug use, as measured by the AUDIT and DUDIT, respectively, indicating 
decreased levels in substance use. Additionally, there was a medium effect size in the 
hypothesized direction in self-judgment, such that participants reported less self-judgment 
between post-assessment and baseline assessment. When baseline and 1-month follow-up scores 






of the outcome measures, including: cravings, GSI, number of days drinking, number of days 
using drugs, and alcohol and drug use as measured by AUDIT and DUDIT, respectively, 
suggesting maintenance of treatment effects. A medium negative effect size was found for self-
soothing, suggesting that individuals were able to maintain their increase in these self-care 
behaviors. When changes in composite self-compassion were assessed between baseline and 1-
month follow-up, a small effect size was found. When changes in self-judgment were assessed 
from baseline to 1-month follow-up the effect size was close to zero, suggesting low 
maintenance of effect (for all self-compassion treatment group effect sizes, see table 7). 
Treatment As Usual Group 
Small-to-medium positive effect sizes (suggesting decreased scores over time) were 
found between baseline and post-treatment in the TAU group in the following outcome 
measures: cravings, GSI, days using alcohol, as measured by the TLFB, and days using drugs, as 
measured by the TLFB. Medium positive effect sizes, suggesting decreased use, were found 
between baseline and post-assessment in alcohol and drug use, as measured by the AUDIT and 
DUDIT, respectively. Additionally, small-to-medium negative effect sizes were found for self-
soothing and self-compassion suggesting that levels of self-compassion and self-soothing 
behaviors increased over time for the TAU group at post-assessment. Finally, a small positive 
effect size was found between baseline and post-treatment in the area of self-judgment, 
suggesting a small decrease in self-judging attitudes over time.  Additionally, effect sizes were 
calculated to assess the strength of change between baseline and 1-month follow-up, with the 
hopes of measuring maintained benefits after treatment ended. Whereas a small effect size was 
maintained for decreased cravings and GSI, and medium effect sizes were maintained for 






of days using drugs, effect sizes for self-soothing, self-compassion, self-judgment and number of 
days drinking became close to zero, suggesting no maintenance of previous gains in these areas. 
Treatment Observations, Reliable Change, and Clinically Significant Change 
Due to the small sample size and repeated case study design of this study, perhaps the 
most appropriate assessment of change over time is through Jacobson and colleagues’ method of 
assessing reliable and clinically significant change. For the purposes of this study, reliable 
change was assessed for each group participant (n = 6) across the following domains: alcohol 
use, drug use, cravings, self-soothing, self-compassion, self-judgment, and GSI. This method 
involves using the formula [c = (M
1
 + M2)/2], where M
1 
is the mean of healthy controls and M
2 
is the score of the participant at post-treatment. If the score of the patient at post-treatment is less 
than c, clinically significant change can be inferred. To determine whether this is a statistically 
significant change, the reliable change index (RCI) is calculated, which involves subtracting the 
patient’s post-treatment score(s) from the pre-treatment score(s), divided by the standard error of 
the estimate (Jacobson & Truax, 1991). This score is then multiplied by 1.96 and if the 
difference in the participants’ scores is greater than the RCI, reliable change is indicated.  
 Additionally, clinically significant change was assessed for all participants for all 
outcome variables. Kendall and Grove (1988) imply that clinically significant change can be 
assessed by comparing a participants’ post-treatment score to the mean of a normative group; if 
the treated person’s score falls within 1 standard deviation of the mean of the normative group, 
then the treated person is undistinguishable from the normative group, and clinically significant 
change can be inferred. In order to calculate this cutoff score, the following formula is used [c = 
M1 +/- SD1] where M1 and SD1 are the mean and standard deviation of the normative group, 






and self-judgment. If no normative data exist, a cutoff score can be calculated by using the 
formula (c = M2 +/- 2(SD2)], M2 and SD2 are the mean and standard deviation of the clinical 
group and a score of 2 standard deviations away from the mean of the clinical sample is 
considered clinically significant change (Jacobson & Truax, 1991). This method will be utilized 
to assess clinically significant change in cravings (Richardson et al., 2008). When assessing 
clinically significant change in alcohol use, a score of 8+ on the AUDIT is a reliable and valid 
identification of hazardous drinking; consequently, this cutoff score will be utilized to assess 
whether or not participants’ substance use better matches those of a clinical or normative 
population after treatment. In one study, Stuart, Moore, Ramsey, and Kahler (2004) found that 
the mean of non-hazardous drug users was 2.7 with a standard deviation of 5.7; consequently, if 
a participants’ drug use score drops to less than 8.4, then clinically significant change can be 
inferred. Clinically significant change could not be calculated for self-soothing, as the only 
norms that exists are from the clinical sample and 2 standard deviations from the mean of the 
clinical sample yields a negative cutoff score.  
 Self-Compassion Treatment Group 
 Qualitative data was collected by group therapists, and reliable and clinically significant 
change were calculated for all outcome variable for each of the six participants who completed 
the treatment, as well as baseline and post-treatment assessment measures. For the purpose of 
best assessing significant change, participants who dropped out of the study between baseline 
and post-assessment can be assumed to have relapsed or not achieved reliable change, as all 
persons who ended their participation in this study also quit the IOP or were asked to leave the 
IOP. Those who dropped out of the study between baseline and post-assessment are included in 






and accurate statistics of treatment success. Overall, of the 10 persons who began the self-
compassion group treatment, the percentages of achieved reliable change or maintained sobriety 
for all outcome variables were: alcohol (50%), drugs (60%), self-judgment (50%), total self-
compassion (40%), cravings (10%), self-soothing (40%), and GSI (20%). More specific statistics 
are reported below, along with treatment notes that may help complete the clinical picture of 
each participant who completed the treatment. For a comparison of these percentages, see Table 
9. For all reliable change statistics in the self-compassion group treatment, see Table 10.   
Participant 101 
Qualitative Data. Participant 101 was a Caucasian male in his mid 30’s working part-
time as a server at a restaurant who presented to the IOP for treatment of his polysubstance 
abuse, after being referred by an employer. He reported being “invested” in mindfulness 
meditation at the first group meeting and expressed great interest in the study for this reason. He 
reported having extensive experience in mindfulness meditation in the past. He attended 3 of the 
5 group therapy sessions and some days participated more than others. In one meeting, he 
appeared to “shut down” approximately halfway through the hour and refused to speak during 
the rest of the session; the following week he did not attend the meeting, but returned for the last 
session and his post-treatment paperwork. Whereas he never shared the explanation for his 
emotional shift during the third session, the group therapists hypothesized that he had a tendency 
to vacillate between high levels of interest and engagement and sudden emotional distance 
without warning. After his emotional “shut down” in the middle of the third session, he never 
returned to his baseline reported level of interest or motivation in the study. During the final 
session, to which he arrived late, the group therapists paid close attention to his emotional 






experience. He seemed disinterested and completed his assessment questionnaires quickly, but 
seemed happy to receive his grocery store gift certificate upon completion. He did not return for 
1-month follow-up assessment, which was not surprising given his decrease in motivation and 
engagement in the study over time. 
  Quantitative Data. Results suggest that Participant 101 achieved reliable change from 
baseline to post-treatment in the areas of: total self-compassion, self-judgment, alcohol use, and 
cravings. Whereas he did report sobriety from drugs during this time, he did not achieve reliable 
change from baseline to post-treatment in this area. The two areas in which Participant 101 did 
not achieve reliable change and/or maintain sobriety were in his self-soothing behaviors and GSI. 
Unfortunately, Participant 101 did not return for 1-month follow-up assessment, so his 
maintenance of improvements was unable to be assessed.  
Clinically significant change was assessed using the previously mentioned methods. 
Participant 101 achieved clinically significant change, or maintained abstinence in the areas of: 
alcohol use (AUDIT = 0), drug use (DUDIT = 1, 1 < 8.4), self-compassion (self-compassion = 
15.83, 15.83 > 15.1), and self-judgment (self-judgment = 3.8, normal range = 2.13-3.80), but did 
not achieve a clinically significant reduction in cravings (cravings = 16, 16 > 4.6) or GSI (GSI = 
1.55, 1.55 > 0.61 cutoff). 
Participant 102  
Qualitative Data. Presenting to the IOP program with a history of alcohol abuse, 
Participant 102 was a homeless and jobless African American male in his late 50’s with a long 
history of alcohol abuse, but no drug use. Despite the many barriers to treatment, including not 
owning a cell-phone to schedule and communicate with the study coordinators, and no access to 






participated in group sessions. He had no previous experience with mindfulness meditation 
practices, but noted in one of the last sessions that the skills he learned had been “very helpful” 
in a stressful interchange with an acquaintance. Whereas it was unclear at the time how or if he 
used the self-compassion skills in the way they were taught, or if he was correctly grasping the 
core themes of self-compassion and its usefulness, it did not seem to matter to this patient. 
Regardless of whether or not he understood the self-compassion teachings, he reported feeling 
connected to the treatment and thus thought of it during times of need, which seemed to help him 
manage his stress in some way. It seemed as though his dedication, connection to the treatment, 
and willingness to openly engage with the group therapists allowed him to feel as though it was 
useful. Unfortunately, he was unable to be reached for follow-up assessment, as the patient was 
homeless, had no phone, and was out of contact with the community mental health center at that 
time.   
 Quantitative Data. Participant 102 achieved reliable change from baseline to post-
treatment in self-judgment and self-soothing. Participant 102 reported no drug use at either 
baseline or post-assessment, and reported total abstinence from alcohol, despite not meeting 
criteria for statistically reliable change in this area. He reported no significant change in total 
self-compassion, cravings, or GSI. At 1-month follow-up, Participant 102 was unable to be 
contacted and thus did not completed questionnaires at this time, resulting in an inability to 
assess whether or not his improvements were maintained.  
 Clinically significant change was assessed at post-assessment and Participant 102’s 
scores suggest that he achieved clinically significant change in the areas of: drug use (drug use = 
0), alcohol use = 0), self-judgment (self-judgment = 2.4, normal range = 2.14-3.80), and self-






change in the areas of cravings (cravings = 13.0, 13.0 > 4.6), or GSI (GSI = 1.89, 1.89 > 0.61 
cutoff). 
 Participant 103   
Qualitative Data. Participant 103 was a 20-year-old Caucasian single female who 
presented to the IOP after a 6-month history of polysubstance abuse. According to Participant 
103, she rarely discriminated between substances and used them to “get rid of” whatever 
emotions she was feeling. She reported having no previous experience with mindfulness 
meditation. At times she arrived late to sessions, which was indicative of her chaotic living 
situation and emotional life; however, once she was present, she was actively engaged and 
showed high levels of insight. She was warm to other group members, respectful, and appeared 
eager to learn. She reported practicing the meditations outside of group multiple times each 
week, noting that she believed them to not only help her feel calm and more in control of her 
emotions, but also allowed her the space to be introspective, which helped her “think more 
clearly” about her future choices. One week she brought to group a piece of writing she 
composed listing the areas in her life with which she wished she had more self-compassion. Of 
all the self-compassion group members, Participant 103 seemed to best grasp the core teachings 
and themes of the self-compassion treatment and made efforts to use these skills to tolerate the 
hurt she felt regarding her recent break-up and even empowered her to feel more worthy of love. 
She attended all 5 sessions, completed all three assessments, and reported feeling sad that she 
would lose contact with the group therapists at the end of the treatment.  
Quantitative Data. Participant 103 achieved reliable change from baseline to post-
treatment in the areas of: total self-compassion, self-judgment, GSI, alcohol use, and drug use. 






to post-treatment assessments, these reduction did not achieve reliable change. When her 
baseline and1-month follow-up reports were assessed, Participant 103 maintained her significant 
improvements in total self-compassion (RCI = 2.79,  = 3.3, p < .05), GSI (RCI = 0.51,  = -
0.63, p <.05) and her reduction in alcohol use (RCI = 10.40,  = - 26.00, p < .05) and drug use 
(RCI = 11.43,  = - 23.00, p < .05). She did not maintain reliable change in self-judgment 
between baseline and 1-month follow-up (RCI = 3.65,  = - 1.00, p > .05). 
 Clinically significant change was assessed for Participant 103’s post-treatment scores and 
suggest that she achieved clinically significant change or abstinence in the areas of: alcohol use 
(alcohol use = 0), drug use (drug use = 0), and self-judgment (self-judgment = 3.2, normal range 
= 2.14-3.80). She did not achieve clinically significant change in self-compassion (self-
compassion = 14.50, 14.50 > 15.1) cravings (cravings = 17.0, 17.0 > 4.6), or GSI (GSI = 1.62, 
1.62 > 0.61 cutoff). 
  Participant 104   
Qualitative Data. Participant 104 was an African American man in his late 50’s with an 
8
th
 grade education, who presented to the IOP for a few year history of alcohol abuse, following 
the loss of his home due to a hurricane. At the time of the study, he was currently unemployed 
and seeking social security assistance. Participant 104 actively participated in sessions and 
attended all five group meetings. He appeared to have a high level of insight and was able to 
actively engage in the mindfulness meditations, often sharing stories about how he used the self-
compassion skills to help “ride the wave” of cravings. He openly shared his experiences in group 
sessions, noting the ways in which learning the self-compassion meditations helped him to feel 
less ashamed about being unable to appropriately care for his children. He shared with the group 






to be a positive influence on his children. His openness and willingness to apply the skills to 
important and relevant life struggles seemed to help him stay connected to and motivated to 
complete the treatment. It should be noted that Participant 104 was one of the few group 
participants who returned 1-month after treatment to complete follow-up questionnaires.  
Participant 104 achieved reliable change from baseline to post-treatment in three areas: 
total self-compassion, self-judgment, and self-soothing. He reported no drug use at either 
baseline or post-assessment, and reported abstinence from alcohol. Despite reporting a reduction 
in cravings and GSI, reliable change from baseline to post-treatment was not found. When 
assessed 1-month after treatment ended, Participant 104 showed maintenance of reliable change 
in the areas of self-judgment (RCI = 3.65,  = - 5.00, p < .05) and self-soothing (RCI = 10.87,  
= 11.00, p < .05), but did not maintain reliable change in his total self-compassion score (RCI = 
2.79,  = 1.66, p < .05). 
Clinically significant change was assessed for Participant 104’s post-treatment scores and 
suggest that he achieved clinically significant change or abstinence in the areas of: alcohol use 
(alcohol use = 0), drug use (drug use = 0), and self-compassion (self-compassion = 19.00, 19.00 
> 15.1).  He did not achieve clinically significant change in cravings (cravings = 6.0, 6.0 > 4.6 
cutoff), self-judgment (self-judgment = 5.0, normal range = 2.14-3.80), or GSI (GSI = 1.36, 1.36 
> 0.61 cutoff). 
 Participant 105 
Qualitative Data. After few year history of drug abuse, Participant 105, age 25, presented 
to IOP after family members encouraged her to seek treatment in order to “recover” and “be a 
better parent” to her young daughter. She had a history of marijuana, opiate and sedative abuse, 






excited to join the study, stating she was partially motivated by the financial incentives and also 
by one of her friends from the IOP, Participant 103, who encouraged her to join. She appeared 
talkative and impulsive at times, and struggled to stay on task. She attended every group session, 
but often appeared disengaged. At times she was found looking at her phone during meditations, 
but noted that the time she spent in group was the “only time each week” she had to sit quietly, 
relax, and focus on herself. Whereas she verbally reported that the study was useful to her, it was 
rare to hear her apply the meditations or self-compassion themes to any of her current life 
stressors. Despite struggling to maintain healthy relationships with her son and significant other, 
she rarely spoke of these issues in group. It was apparent that she joined the IOP because family 
members recommended she seek treatment, and that she joined the self-compassion study 
because her friend suggested they do it together. This is a patient who seemed to struggle with 
self-identity and would likely have benefitted from gained insight in this area before engaging in 
a mindful self-compassion study.  
Quantitative Data. She achieved reliable change from baseline to post-treatment in the 
areas of: total self-compassion, self-judgment, drug use, self-soothing, and GSI. Participant 105 
reported abstinence from alcohol use, although did not achieve reliable change. She did not meet 
criteria for reliable change in cravings. At 1-month follow-up, Participant 105 showed 
maintained reliable change in the areas of total self-compassion (RCI = 2.79,  = 6.2, p < .05), 
self-judgment (RCI = 3.65,  = - 5.00, p < .05), drug use (RCI = 11.43,  = - 14.00, p < .05), 
GSI (RCI = 0.51,  = -0.53, p<.05) and self-soothing (RCI = 10.87,  = 24.00, p < .05). 
Clinically significant change was assessed for Participant 105’ post-treatment scores and 
suggest that she achieved clinically significant change or abstinence in the areas of: alcohol use 






> 15.1).  She did not achieve clinically significant change in cravings (cravings = 11.0, 11.0 > 
4.6 cutoff), self-judgment (self-judgment = 5.0, normal range = 2.14-3.80), or GSI (GSI = 1.09, 
1.09 > 0.61 cutoff). 
 Participant 106  
Qualitative Data. Participant 106 was a 59-year-old Caucasian male brought to the IOP 
by himself after a long on-and-off history of alcohol abuse. He was currently unemployed, but 
previously had a successful work history. Unlike some of the other group members, Participant 
106 had practiced mindfulness meditations in the past, which initially drew him to the study. He 
was well versed in the benefits of such practices and reported enjoying the group immensely, as 
it helped him “get back into” using meditation to help improve his overall level of functioning. 
He used his experience with mindfulness meditation to help other group members tailor the 
mindfulness techniques to be more appropriate for their specific circumstances. Although he 
noted that these practices benefitted him, he rarely used time in group to share how the self-
compassion meditations applied to his current emotional and social stressors, and instead often 
acted as an “unofficial” group leader, sharing his suggestions for improving the mindfulness 
practices of other group members. Additionally, at times he presented with rigid thinking and an 
advantaged attitude and he became frustrated with the group leader upon finding out that he 
could not participate in the group a second time after completing the program and worked to 
negotiate with the group leaders to make an exception for him. He did attend all five group 
sessions and completed all three assessments.  
Quantitative Data. Participant 106 achieved reliable change from baseline to post-
treatment in the area of alcohol use and reported abstinence from drugs. He showed no 






compassion scores increased and his GSI decreased, neither met criteria for reliable change. At 
1-month follow-up, Participant 106 maintained reliable change in decreased alcohol use (RCI = 
10.40,  = - 12.00, p < .05).  
Clinically significant change was assessed for Participant 106’s post-treatment scores and 
suggest that he achieved clinically significant change or abstinence in the areas of: alcohol use 
(alcohol use = 1, 1 < 8 cutoff), drug use (drug use = 0), and self-judgment (self-judgment = 3.00, 
normal range = 2.14-3.80). He did not achieve clinically significant change in cravings (cravings 
= 24.00, 24.00 > 4.6 cutoff), self-compassion (self-compassion = 13.33, 13.33 < 15.1 cutoff), or 
GSI (GSI =2.49, 2.49 > 0.61 cutoff). 
 Treatment As Usual Group 
Whereas less clinically relevant information was gathered about the treatment as usual 
study participants, RCI and clinically significant change were calculated for these individuals, as 
well, to assess whether or not they achieved reliable change without the self-compassion group 
treatment. Overall, of the 10 TAU participants, 7 completed post-assessment measures; the 3 
persons who dropped out of the study between baseline and post-assessment can be considered to 
have relapsed or not achieved statistically significant change, as they also were either asked to 
leave the IOP or quit without warning. The percentages of achieved reliable change or 
maintained sobriety for all outcome variables were: alcohol (60%), drugs (60%), self-judgment 
(40%), total self-compassion (30%), cravings (30%), self-soothing (20%), and GSI (40%). See 
Table 9 for a comparison of percentages of change. For specific reliable change scores for the 
TAU group, see Table 11.  
 Participant 201. Working as a full-time cashier, Participant 201 was a 35-year-old 






treatment, and 1-month follow-up measures for this study. She achieved reliable change between 
baseline and post-IOP assessment in only one area: drug use. She did not achieve reliable change 
in the following outcome variables: total self-compassion, self-judgment, self-soothing, cravings, 
GSI, or alcohol use; however, it should be noted that she did not report high levels of alcohol 
abuse at baseline and instead reported a history of drug use. When her baseline scores were 
compared to her 1-month-follow up scores, her drug use increased from post-assessment to 1-
month follow-up, but she maintained reliable change, despite this (RCI = 11.43,  =  -18.00, p < 
.05). 
Clinically significant change was assessed for Participant 201’s post-treatment scores and 
suggest that she achieved clinically significant change or abstinence in the areas of: alcohol use 
(alcohol use = 5, 5 < 8 cutoff), drug use (drug use = 7.00, 7.00 < 8.4 cutoff), and she did not 
achieve clinically significant change in cravings (cravings = 15.00, 15.00 > 4.6 cutoff), self-
judgment (self-judgment = 1.40, normal range = 2.14-3.80), self-compassion (self-compassion = 
9.00, 9.00 < 15.1 cutoff), or GSI (GSI = 2.89, 2.89 > 0.61 cutoff). 
 Participant 202. Participant 202 was a 35-year-old single male with no children working 
in retail part-time. He participated in the baseline and post-IOP assessments, but was unable to 
be reached for the 1-month follow-up questionnaires. He achieved reliable change between 
baseline and post-IOP assessment in the following areas: total self-compassion, self-judgment, 
cravings, GSI, and alcohol use. He did not achieve reliable change in the areas of self-soothing 
or drug use, reporting 1 use each of stimulants, cannabis, cocaine, and hallucinogens during the 
30 days prior to the post-IOP assessment. This participant did not return for follow-up 






Clinically significant change was assessed for Participant 202’s post-treatment scores and 
suggest that he achieved clinically significant change or abstinence in the areas of: drug use 
(drug use = 0) and self-judgment (self-judgment = 2.60, normal range = 2.14-3.80). He did not 
achieve clinically significant change in alcohol use (8.00, 8.00 = 8.00 cutoff), cravings (cravings 
= 16.00, 16.00 > 4.6 cutoff), self-compassion (self-compassion = 13.00, 13.00 < 15.1 cutoff), or 
GSI (GSI = 2.09, 2.09 > 0.61 cutoff). 
 Participant 203. Participant 203 was a 44-year-old Caucasian male with some college 
education who participated in the TAU group of this study and completed assessment measures 
at all 3 time-points. He achieved reliable change between baseline and post-IOP assessment in 
the areas of: total self-compassion, self-judgment, self-soothing, GSI, reported no alcohol use at 
either baseline or post-assessment, and reported full sobriety from drugs while in the IOP 
(although he did not achieve reliable change due to reporting a low amount of drug use at 
baseline assessment). Despite maintaining sobriety, he did not achieve reliable change in 
cravings. When his baseline scores were compared to his 1-month follow-up, Participant 203 
maintained reliable change in the area of total self-compassion and maintained sobriety from 
drugs and alcohol, but did not maintain his change in self-soothing, self-judgment, or GSI, and 
did not gain reliable change in cravings. 
Clinically significant change was assessed for Participant 203’s post-treatment scores and 
suggest that he achieved clinically significant change or abstinence in the areas of: alcohol use 
(alcohol use = 4, 4 < 8 cutoff), drug use (drug use = 3.00, 3.00 < 8.4 cutoff), and self-judgment 
(self-judgment = 2.20, normal range = 2.14-3.80). He did not achieve clinically significant 
change in cravings (cravings = 24.00, 24.00 > 4.6 cutoff), self-compassion (self-compassion = 






 Participant 204. Working part-time as a bus driver, Participant 204 was a 51-year-old 
Caucasian male who participated in the TAU group and completed baseline and post-IOP 
assessment measures. He achieved reliable change from baseline to post-IOP in the following 
areas: alcohol use, cravings, and quit using drugs, but did not achieve reliable change in this area 
due to reporting a low baseline drug use. He did not achieve reliable change in the areas of total 
self-compassion, self-judgment, GSI, or self-soothing. Maintained change was unable to be 
assessed due to the participant being unreachable to return for follow-up assessment.  
Clinically significant change was assessed for Participant 204’s post-treatment scores and 
suggest that he achieved clinically significant change or abstinence in the areas of: drug use 
(drug use = 0) and self-judgment (self-judgment = 3.40, normal range = 2.14-3.80). He did not 
achieve clinically significant change in alcohol use (alcohol use = 8.00, 8.00 = 8 cutoff), cravings 
(cravings = 8.00, 8.00 > 4.6 cutoff), self-compassion (self-compassion = 14.00, 14.00 < 15.1 
cutoff), or GSI (GSI = 1.60, 1.60 > 0.61 cutoff). 
 Participant 205. Participant 205 was a 25-year-old college educated unemployed female 
who participated in the TAU arm of the study. She completed baseline and post-IOP 
questionnaires, but did not return for follow-up assessment and was unreachable by phone. When 
the changes in scores from baseline to post-IOP, she achieved reliable change in the areas of:  
total self-compassion, self-judgment, self-soothing, GSI, drug use, and completely quit using 
alcohol; however, she was using so little to start that it appears as though she did not achieve 
reliable change in this area. She did not achieve reliable change in the areas of cravings. Since 
this participant did not return for follow-up assessment, her gains were unable to be assessed for 






Clinically significant change was assessed for Participant 205’s post-treatment scores and 
suggest that she achieved clinically significant change or abstinence in the areas of: alcohol use 
(alcohol use = 1.00, 1.00 < 8 cutoff), drug use (drug use = 0). She did not achieve clinically 
significant change in cravings (cravings = 10.00, 10.00 > 4.6 cutoff), self-judgment (self-
judgment = 4.00, normal range = 2.14-3.80), self-compassion (self-compassion = 15.00, 15.00 < 
15.1 cutoff) or GSI (GSI = 1.40, 1.40 > 0.61 cutoff). 
Participant 206. Participant 206 was a 35-year-old unemployed and single Caucasian 
male who completed the IOP, as well as baseline, post-IOP, and 1-month follow-up 
questionnaires for the TAU group of this study. He achieved reliable change from baseline to 
post-IOP in the areas of: cravings, self-judgment, GSI, alcohol use, and quit using drugs all-
together; however, he was using so little to start that it appears as though he did not achieve 
reliable change in this area. He did not achieve reliable change in the areas of total self-
compassion or self-soothing. When his baseline and 1-month follow-up scores were compared, 
participant 206 maintained reliable change in the areas of: alcohol use, cravings, GSI, and self-
judgment. He reported a slight increase in drug use between post-assessment and 1-month 
follow-up, but still reported less drug use at follow-up than his baseline report. Finally, he 
continued to show no reliable change in the areas of total self-compassion or self-soothing.  
Clinically significant change was assessed for Participant 206’s post-treatment scores and 
suggest that he achieved clinically significant change or abstinence in the areas of: drug use 
(drug use = 0) and self-judgment (self-judgment = 3.20, normal range = 2.14-3.80). He did not 
achieve clinically significant change in alcohol use (alcohol use = 9.00, 9.00 > 8 cutoff), cravings 
(cravings = 15.00, 15.00 > 4.6 cutoff), self-compassion (self-compassion = 11.83, 11.83 < 15.1 






 Participant 207. Participant 207 was a 36-year-old unemployed and single African-
American male who completed the IOP, as well as baseline, post-IOP, and 1-month follow-up 
questionnaires for this study. He maintained sobriety and achieved reliable change in the area of 
alcohol use, and reported no drug use at baseline or post-assessment. He did not achieve reliable 
change in the areas of total self-compassion, self-judgment, cravings, GSI, or self-soothing. He 
returned 1-month after IOP ended to complete follow-up questionnaires for this study and 
maintained sobriety and reliable change in alcohol use and maintained sobriety from drugs. 
Similarly to his scores at post-assessment, he did not achieve reliable change from baseline to 
follow-up in total self-compassion, self-judgment, cravings, GSI, or self-soothing.  
Clinically significant change was assessed for Participant 207’s post-treatment scores and 
suggest that he achieved clinically significant change or abstinence in the areas of: alcohol use 
(alcohol use = 2.0, 2.0 < 8 cutoff), drug use (drug use = 0) and self-judgment (self-judgment = 
3.20, normal range = 2.14-3.80). He did not achieve clinically significant change in cravings 
(cravings = 8.00, 8.00 > 4.6 cutoff), self-compassion (self-compassion = 11.67, 11.67 < 15.1 
cutoff), or GSI (GSI = 1.42, 1.42 > 0.61 cutoff). 
Anecdotal Data 
 IOP members and study participants offered feedback throughout this 9-month study. 
First, it should be noted that there was a strong interest in participation in this study, and in 
particular, most participants indicated that they hoped to receive the self-compassion group 
therapy, instead of the TAU. In fact, some TAU participants reported feeling disappointed that 
the study was no longer recruiting self-compassion group treatment participants, as they had 
heard other IOP members voice positive reviews of the treatment. Additionally, a few of the self-






together, many group participants indicated interest in ongoing mindfulness meditation practice 
to be offered within the structure of their ongoing substance use treatment. 
 In regards to feedback related to specific aspects of the self-compassion group treatment, 
most members indicated that the most useful aspect of the protocol was the established time each 
week to focus on relaxation, self-care, and acceptance. The group members noted that the 
protocol was accessible and easy to understand, despite differences in education level, racial and 
ethnic backgrounds, SES, and previous experience with mindfulness meditations. Whereas a few 
members struggled at times to verbalize the ways in which the self-compassion meditations 
helped them when they practiced outside of session times, most members seemed to connect to 
the program, as evidenced by good attendance during the treatment phase of the study and 
openness in sessions. Three of the 10 self-compassion participants noted that the most difficult 
aspect of the treatment was the fifth and final session that involved participants offering 
compassion to others, even those towards whom you experience negative or painful feelings.  
Overall, the group therapists were struck by the insight and openness of group members 
who shared their successes and struggles with efforts to stay clean and sober. No changes were 
made to the protocol during this study; however, for those participants who struggled to 
articulate the benefits of the self-compassion meditations would have likely benefitted from more 






Section 4: Discussion 
This current paper assessed the effectiveness of a brief adjunctive self-compassion group 
treatment in a sample of persons in an intensive outpatient program for substance use. Informed 
by Germer’s (2009) meditation skills to increase levels of self-compassion, the treatment was 
designed for this study by these co-authors. To the best knowledge of these authors, this is the 
first attempt to test a self-compassion treatment in a substance-using sample. The preliminary 
nature of this study aimed to a) identify whether individuals who received the treatment did, in 
fact, experience increases in self-compassion, b) explore the associations and changes throughout 
treatment between self-compassion, substance use and cravings, self-judgment, compassionate 
self-soothing, and general symptom severity, c) evaluate participants’ experienced reliable and 
clinically significant change as a result of receiving the self-compassion group treatment or TAU 
and d) determine effect sizes to perhaps inform the research design of future randomized control 
studies regarding this treatment.  
Specifically, it was hypothesized that self-compassion would be negatively associated 
with substance use, cravings, and overall symptom severity (as measured by the Global Severity 
Index (GSI) score on the Brief Symptom Inventory; Derogatis & Melisaratos, 1983), and 
positively associated with compassionate self-soothing at baseline, post-treatment, and 1-month 
follow-up. Results of such analyses suggested that self-compassion was significantly associated 
in the hypothesized direction with drug use and GSI at baseline; at post assessment, self-
compassion was significantly associated with drug use, GSI and self-soothing, and at 1-month 
follow up assessment, self-compassion was associated with GSI and self-soothing. Overall, these 
findings match previous research that suggests that self-compassion is associated with more 






noted that self-compassion was not correlated with alcohol use at any time point. Given the 
negative relation between self-compassion and alcohol use that is found in previous studies (e.g,, 
Rendon, 2006; Brooks, Kay-Lambkin, Bowman, & Childs, 2012), the explanation for this result 
is unclear. Although most other outcome variables were correlated with self-compassion in the 
expected direction, given the low number of participants in this study, it is possible that this 
finding is just an artifact of this data set and thus replication is needed. 
Additionally, it was hypothesized that self-compassion would increase throughout the 
course of the treatment and would be maintained through post and 1-month follow-up 
assessments. A within subjects repeated measure design was used for this study, as it allows 
statistical inference to be made with fewer subjects than a between subjects design would require 
(Keren, 2014). Whereas some participants experienced increases in levels of self-compassion, 
time had no significant main effect on self-compassion or any of the components of self-
compassion, when posthoc analyses were conducted. Additionally, results suggested that there 
was no significant main effect of time on alcohol use, drug use, or self-soothing behaviors. The 
only outcome variable that significantly changed over time was cravings, which could be 
explained by multiple theories. First, given the neurobiological nature of cravings, research 
consistently shows that with reduced use or abstinence, cravings naturally decrease over time 
(e.g., Shiffman, et al., 1997). Since abstinence was strongly encouraged in the IOP for both self-
compassion group treatment and TAU, it is possible that the reduction in use was related to a 
decrease in cravings. Additionally, research suggests that negative emotional experiences often 
lead to cravings, and one study found that implementing a “Coping with Cravings and Urges” 
module, which included psychoeducation about cravings and “urge-surfing” exercises, helped 






(Witkiewitz, Bowen, & Donovan, 2011). For all participants in this study, psychoeducation and 
skills instruction were an important focus of the IOP, and results of this study suggest that this 
emphasis may have helped all participants reduce their cravings. Whereas the only significant 
change that occurred over time was a reduction in cravings, it is not altogether surprising that 
most outcome variables were not found to change over time; given the very small number of 
participants and the high attrition that is often seen in substance using samples, this study was 
limited in the number of participants who completed all three assessments. Consequently, it is 
possible that with more participants, and an increase in power, more associations and changes 
over time would be found. 
 Furthermore, this study hypothesized that the effect sizes of the outcome variables in the 
self-compassion treatment group would be stronger than the effect sizes of the outcome variables 
in the TAU group. Overall, the effect sizes for both the self-compassion group treatment and 
TAU were very similar, although the effect sizes in the self-compassion group tended to be 
larger on the measures most closely related to self-compassion. Furthermore, another notable 
difference between the groups was the self-compassion group treatment’s maintenance of 
benefits in self-soothing and self-compassion at follow-up assessment. Specifically, the self-
compassion treatment group showed the maintenance of effect at 1-month follow-up in self-
soothing behaviors, whereas the medium effect found in increased self-soothing from baseline to 
post-assessment in the TAU group became close to zero 1-month post-treatment. Additionally, 
whereas the TAU group’s effect of increased self-compassion was not maintained at follow-up, a 
small effect size was maintained for the self-compassion group treatment in this area. Stronger 
and more better maintained effect sizes in self-compassion and self-soothing behaviors for those 






meditation may help to increase positive self-care behaviors in multiple ways. This effect might 
be due to the fact that individuals higher in self-compassion are less likely to suppress unwanted 
thoughts and are more willing to validate their emotional experiences, both positive and negative 
(Leary et al., 2007).  These kinds of behaviors are indicative of a less punitive way of self-
relating, and perhaps promote more willingness to take care of and soothe oneself, rather than 
berate oneself.  
Whereas both groups seemed to improve in areas of alcohol use, drug use, and cravings, 
all of which were emphasized in the IOP and in all substance use treatment programs, only those 
in the self-compassion group treatment maintained the improvements in self-compassion and 
self-soothing behaviors, which were a key emphasis of the mindful self-compassion meditation 
groups. This suggests that the self-compassion group treatment alone may not have significantly 
influenced or improved participants’ substance use or cravings over and above the effects of the 
IOP, but self-compassion group participants did seem to gain more self-soothing abilities. 
Whereas the self-compassion group treatment may not have significantly affected participants’ 
substance use and cravings, it should be noted the brief treatment was comprised of five 1-hour 
mindful meditation groups, when compared to 9-hours per week for eight weeks that IOP 
members spent in the community mental health center’s program.  
Furthermore, the results of the reliable change and clinically significant change statistics 
suggested some support of the current study hypotheses. The data suggest that perhaps more self-
compassion group treatment participants achieved reliable change in self-soothing. The primary 
difference in clinically significant change was seen with self-compassion. Specifically, 40% of 
the self-compassion group achieved clinically significant change in overall self-compassion, 






Clinically significant change was unable to be calculated for self-soothing behaviors, and there 
was little difference in drug and alcohol use and self-judgment between treatment and TAU 
groups. Overall, these findings mirror the effect size findings that suggested that those who 
received the self-compassion group treatment may gain and maintain stronger benefits in 
viewing themselves more compassionately and behaving in more self-nurturing ways.  
 Interestingly, more TAU participants achieved reliable change in reduction of cravings 
(30%) when compared to the 10% of self-compassion treatment participants who experienced a 
reliable change reduction in cravings. Additionally, although 40% of the TAU participants 
reported a reliable change in reduction of overall symptoms, as measured by the GSI, only 20% 
of the self-compassion treatment participants experienced a reliable reduction in overall 
psychological symptoms. Whereas it appears that those who received the self-compassion 
treatment did not achieve as much reduction in cravings or symptom relief as those in the TAU 
group, it is possible that the intended increased awareness and acceptance of participant’s 
thoughts, feelings, and bodily sensations resulted in an amplified, and thus perhaps more 
accurate and more negative, view of one’s experiences. Specifically, in Session 1: Mindfulness 
and Session 3: Difficult Emotions, participants were asked to pay close attention to the parts of 
their bodies that were feeling tense and notice where in their bodies they experienced negative 
and painful thoughts and emotions. Perhaps this increase in bodily and emotional reactions 
allowed the self-compassion group participants to more accurately label their symptoms, 
feelings, and cognitions, than those in the TAU group who may not have been encouraged to pay 
as close attention to their physical and emotional experiences (e.g., those who are continuing the 
avoidance of ones’ symptoms). It is possible that with more time and practice, study participants 






week participation in this study. In fact, a recent study by Neff and Germer (2013) found that 
increases in self-compassion were related to the number of days per week that individuals 
meditated, as well as the number of times per day that participants practiced informal self-
compassion.  
 Furthermore, the anecdotal data that was collected in the form of verbal feedback to the 
study recruiters, self-compassion group therapists, and IOP leaders, suggested that overall self-
compassion group participants were pleased with the five session adjunctive treatment. 
Participants gave this feedback directly to the group therapists, IOP leaders, and other IOP 
members who were not participating in the study. This word-of-mouth positive feedback 
increased participant interest in the study, and many were disappointed when the study no longer 
recruited for the self-compassion group and only offered TAU participation. This may help 
explain why it took approximately five months to recruit all 10 participants in the TAU group, as 
opposed to the two months it took to recruit for the self-compassion treatment group. For those 
who received the self-compassion group treatment, many reported that the most difficult task 
was practicing the mindful compassion for themselves and for others who have hurt them in the 
past. It is possible that the self-criticism and shame that is often so high in substance using 
populations make it difficult to look kindly towards the self. Furthermore, it is quite difficult to 
offer compassion to others with whom you find it challenging to love; consequently, it is 
possible that with more time and practice, this specific meditation would become easier. 
 When participant characteristics were assessed, the group therapists noticed some 
differences that may have affected participant engagement with and the achieved benefits from 
the self-compassion group treatment. Specifically, it seemed as though neither of the two 






achieved reliable change in the area of self-soothing behaviors, while 3 of the 4 participants who 
had no prior experiences with mindfulness achieved reliable change in self-soothing. It is 
possible that participants with previous mindfulness experience may have already achieved 
improvements in self-soothing prior to treatment, and may not have learned enough “new” 
information or skills to achieve a reliable change in this area. Alternatively, it is possible that 
those with previous meditation experience were not able to approach the task with a beginners 
mind and were more invested in appearing as though they were proficient in the practice. 
Additionally, there seemed to be differences in engagement in the treatment, which likely 
impacted the benefits. Specifically, participants who joined the IOP on their own will, and were 
not referred by family members or coworkers, engaged more fully with the study, as evidenced 
by improved attendance and focus during sessions. Furthermore, participants who actively and 
accurately applied the meditations and self-compassion skills to their current life stressors 
seemed to engage more fully in the study, as evidenced by improved attendance rates and 
commitment to completion of the study. These findings are not uncommon in treatment outcome 
research, where higher levels of engagement, motivation, and readiness to change are linked to 
improved outcomes in therapy, and in substance use treatment, in particular (e.g., Miller & 
Rollnick, 1991; Miller & Wilbourne, 2002). Perhaps those who are intrinsically motivated for 
treatment and change are also more open to allowing the treatment program to change their 
current way of functioning.  
Limitations and Future Directions 
Findings from this study further support previous studies that have found a significant 
relation between self-compassion and problematic substance use, and drug use in particular (e.g., 






review; Rendon, 2006). Additionally, this longitudinal study assessed the benefits of the self-
compassion group treatment designed for the purpose of this study. Despite findings that suggest 
that self-compassion may be related to drug use, and that a self-compassion group treatment 
might elicit long term improvements in self-compassion and self-soothing behaviors, this study 
is not without limitations. 
Perhaps the most glaring limitation is that of the sample size and attrition rate. As 
previously mentioned, 10 participants completed baseline measures and began the self-
compassion group and four of those 10 dropped out of the study before the five treatment 
sessions were complete (60% of participants completed the treatment). Another two were unable 
to be reached for follow-up measures 1-month after the treatment ended (33% of those who 
completed the treatment), resulting in only four persons from the treatment group who completed 
the study from start to finish. Because of the small sample size and high attrition rates, many of 
the hypothesized relations between self-compassion and other outcome variables possibly were 
not detected, likely due to low power and an insufficient sample size. Poor retention rates are a 
challenge in most substance use research (e.g., McCaul, Svikis, & Moore, 2000); however, the 
attrition rates in this study are particularly low, and thus, very problematic for statistical reasons. 
In addition to the increased vulnerability towards drop-out and relapse found in substance users, 
given the limited resources of this particular sample (financial, social support), it is not surprising 
that many participants left the study and were unreachable by phone. It should be noted that 
100% of the persons who dropped out of this study either relapsed and dropped out of the entire 
intensive outpatient program at the community mental health center, or were asked to leave the 
program due to IOP leaders’ concern with patient dishonesty about substance use. Whereas study 






even without continuing in the IOP- and assured that there would be no negative consequences- 
none continued. It is likely that returning to the location of the IOP was too shaming or 
uncomfortable for these patients. In an effort to build on the findings of this study, future 
research should recruit more participants, in order to increase power and allow for further 
statistical analyses, including stronger correlations, between subjects-designs, and more accurate 
effect sizes.  
In an effort to determine whether study participants changed as a result of the self-
compassion treatment, TAU participants were assessed. Whereas the 8-week IOP included no 
mindfulness or self-compassion related skills instruction, it is likely that participants receiving 
any substance use treatment would benefit in areas related to: reduced alcohol and drug use, 
cravings, and even some self-care behaviors. Furthermore, all IOP members were required to 
attend at least two AA/NA meetings each week and the AA/NA program includes aspects of 
self-compassion, including acceptance, recognizing the importance of community support and 
shared experiences (common humanity). Specifically, Germer (2009) explains that:  
When an Alcoholics Anonymous (AA) member says at a meeting, ‘I’m an alcoholic,’ he 
 or she is speaking from a larger frame of self-acceptance- nothing to hide. Resisting the 
 idea that one is an alcoholic, or becoming engulfed in shame when a relapse occurs, can 
 be obstacles of staying clean and sober. (p. 215)  
Consequently, all IOP members, and therefore all study participants, were interacting with 
themes and issues related to self-compassion throughout their time in treatment at the community 
mental health center. Subsequently, even if AA/NA attendees were not explicitly taught 
mindfulness meditations and self-compassion techniques, the implicit value of self-acceptance 






Due to the small sample size, between-group analyses were unable to be conducted; 
consequently, it is difficult to know how much more the self-compassion group improved 
participants’ self-care behaviors. Additionally, the adjunctive self-compassion group treatment 
was only five sessions in total; it is likely that with more sessions and more practice, participants 
would achieve more benefits from the newly learned skills. This, paired with the positive 
feedback given to the group therapists by the self-compassion group participants, suggest that 
future studies should strive to lengthen the number of treatment sessions, in order to allow 
participants more time, experience, and practice with the mindfulness skills. Additionally, given 
the interest in participation in the treatment arm of this study, and the potential improvements in 
self-compassion and self-soothing behaviors, perhaps the existing IOP curriculum would benefit 
from including psychoeducation on self-compassion and teaching mindful self-compassion 
meditations.  
Finally, random assignment is the ideal methodology of treatment outcome research (e.g., 
Abel & Koch, 1999). Random assignment equates the groups on all known and unknown 
extraneous variables at the beginning of the study, which increases the likelihood that any 
significant observed differences between groups can be attributed to the effect of the treatment. 
Because this study was exploratory in nature and the authors wanted to ensure a certain number 
of participants received the self-compassion group treatment, all self-compassion group 
treatment participants were recruited before the TAU data were collected and a repeated case-
study methodology was employed. It is possible that some of the differences seen between the 
groups in this study are at least partially explained by unknown confounding variables, rather 
than differences that can be attributed to the treatment; however, the two groups were quite 






controlled trial design, in order to best distinguish treatment effects from other confounding 
variables related to group bias. 
General Discussion 
This exploratory repeated case-study piloted a mindful self-compassion group treatment 
for substance users in an intensive outpatient program. This study found that self-compassion 
may be related to decreased drug use, cravings, general psychological symptoms, and self-
soothing behaviors at various time-points in the study. Whereas alcohol use was not correlated 
with self-compassion in this study, it is possible that this is either an artifact of this small sample 
size, or future studies should be completed in order to better identify if self-compassion has a 
different relation to alcohol and drug use. Results of this study found a significant reduction in 
cravings for all study participants (both in the self-compassion group therapy and TAU) over the 
course of the 12-week involvement in the study. With regards to differences between the self-
compassion group and the TAU group, efforts to increase self-compassion (through a mindful 
self-compassion meditation group treatment) were found to be effective in this population, and 
significant increases in self-soothing behaviors were found for those who completed the self-
compassion treatment (those who were in the TAU group did make gains in self-compassion and 
self-soothing at post-assessment, but did not maintain significant gains at 1-month follow-up in 
either area). Although this study is limited in sample size, and subsequently was unable to 
formally assess between-group differences, it is possible that future studies in this area may find 
similar results and may be able to help illuminate the methods through which self-compassion 
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Appendix A: Tables  
Table 1: Descriptive Statistics at Baseline Assessment 
 N Minimum Maximum Mean Std. Deviation 
AUDIT 20 1.00 30.00 16.40 10.16 
DUDIT 20 0.00 34.00 14.90 12.09 
Cravings 20 5.00 34.00 20.10 7.75 
Self-Compassion 20 5.67 18.67 11.61 3.55 
Self-Judgment 20 10.00 25.00 16.95 4.99 
Self-soothing 20 5.00 28.00 21.70 9.54 
GSI 20 1.17 4.13 2.17 0.83 
 














AUDIT 1.00 - - - - - - 
DUDIT -0.38 1.00 - - - - - 
Cravings 0.01 -0.12 1.00 - - - - 
Self-
compassion 
0.31 -0.63** -0.12 1.00 - - - 
Self-judgment -0.39 0.58** 0.29 - 1.00 - - 
Self-soothing 0.23 -0.29 0.16 0.25 -0.14 1.00 - 
GSI -0.34 0.34 0.56* -0.71** 0.61* -0.19 1.00 






















AUDIT 1.00 - - - - - - 
DUDIT 0.57 1.00 - - - - - 
Cravings 0.01 0.28 1.00 - - - - 
Self-
compassion 
-0.32 -0.60* -0.45 1.00 - - - 
Self-judgment 0.55* 0.62* 0.54 - 1.00 - - 
Self-soothing -0.18 -0.43 -0.02 0.77** -0.42 1.00 - 
GSI 0.31 0.62* 0.50 -0.64* 0.78** -0.40 1.00 
* = p < .05, ** p < .01 














AUDIT 1.00 - - - - - - 
DUDIT 0.29 1.00 - - - - - 
Cravings 0.40 0.74* 1.00 - - - - 
Self-
compassion 
-0.23 -0.62 -0.85** 1.00 - - - 
Self-judgment 0.19 0.61 0.69 - 1.00 - - 
Self-soothing -0.08 -0.37 -0.74* 0.77* -0.64 1.00 - 
GSI 0.52 0.50 0.90** -0.72* 0.61 -0.74* 1.00 






















AUDIT 1.00 - - - - - - 
DUDIT -0.68 1.00 - - - - - 
Cravings 0.20 -0.06 1.00 - - - - 
Self-
compassion 
-0.25 -0.68 0.20 1.00 - - - 
Self-judgment 0.37 0.27 0.01 - 1.00 - - 
Self-soothing 0.66 0.25 -0.67 -0.04 -0.52 1.00 - 
GSI 0.69 -0.81* -0.11 -0.93** 0.72 0.60 1.00 
 
 
Table 6: Change in Cravings Over Time 
 Type III Sum of Squares df Mean Square F Sig. 
Time Effect 
Sphericity Assumed 














Table 7. Effect Sizes for Self-Compassion Group Participants.  
 Cohen’s d 
T1-T2 




Effect Size (r) 
T1-T3 
AUDIT d = 1.69 r = 0.65 d = 1.90 r = 0.69 
DUDIT d = 1.57 r = 0.62 d = 1.56 r = 0.61 
# Days Drinking d = 0.71 r = 0.34 d = 1.07 r = 0.47 
# Days Using Drugs d = 0.93 r = 0.42 d = 0.84 r = 0.39 
Cravings d = 0.87 r = 0.40 d = 1.83 r = 0.67 
Self-Compassion d = -1.15 r = -0.50 d = -0.34 r = -0.17 
Self-Judgment d = 0.93 r = 0.42 d = 0.22  r = 0.11 
Self-Soothing d = -1.35 r = -0.56 d = -0.83 r = -0.38 

















Table 8. Effect Sizes for Treatment As Usual Group 
 Cohen’s d 
T1-T2 




Effect Size (r) 
T1-T3 
AUDIT d = 1.48 r = 0.59 d = 1.08 r = 0.48 
DUDIT d = 1.62 r = 0.63 d = 1.80 r = 0.67 
# Days Drinking d = 0.92 r = 0.42 d = 0.37 r = 0.18 
# Days Using Drugs d = 0.95 r = 0.43 d = 1.20 r = 0.52 
Cravings d = 0.85 r = 0.39 d = 0.70 r = 0.33 
Self-Compassion d = -0.74 r = 0-.35 d = 0.05 r = 0.03 
Self-Judgment d = 0.46 r = .23 d = 0.14 r = 0.07 
Self-Soothing d = -0.75 r = -0.35 d = -0.14 r = 0.07 
GSI d = 0.79 r = 0.37 d = 0.43 r = 0.21 
 









AUDIT 50% 60% 50% 40% 
DUDIT 60% 60% 60% 70% 
Cravings 10% 30% 0% 0% 
Self-Compassion 40% 30% 40% 0% 
Self-Judgment 50% 40% 40% 50% 
Self-Soothing 40% 20% - - 





















RCI = 2.79 
Self-
Judgment 







RCI = 0.51 
101  = - 
23.00* 
 = - 8.00 
abstinent 
 = - 
10.00* 
 = 3.83*  = - 
5.00* 
 = 1.00  = -0.41 
102  = - 3.00 
abstinent 
 = 0.00 
abstinent 




 = -0.32 
103  = - 
26.00*^ 
 = - 
23.00*^ 
 = - 2.00  = 4.5*^  = - 
4.00* 
 = 7 .00  = -
0.63*^ 
104  = - 7.00 
abstinent 
 = 0.00 
abstinent 




 = -0.02 
105  = - 6.00 
abstinent 
 = - 
14.00* 






106  = - 
13.00* 
 = - 
6.00* 
 = 0.0  = 1.5  = 0.0  = - 
5.00 
 = -0.13 
* = p < .05; ^ = maintained RC at follow-up.  
 




























201  = 3.0 
abstinent 
 =  -
24.00*^ 
 = -7.00  = 1.13  = -1.00  = 4.00  = -0.15 
202  = -
23.00* 
 =  -5.00  = -
14.00* 
 = 4.5*  = -5.00*  = -4.00  = -0.70* 
203  = 0.0^ 
abstinent 
 =  -
1.00^ 
abstinent 
 = -2.00  = 5.5*^  = -5.00*  = -
20.00* 
 = -1.38* 
204  = -
16.00* 
 =  -9.00 
abstinent 
 = -12.00  = 0.02  = -1.00  = -2.00  = -0.12 
205  = - 6.00 
abstinent 
 =  -
34.00* 




 = -1.11* 
206  = -
16.00*^ 




 = 1.17  = -
8.00*^ 
 = -1.00  = -
1.81*^ 
207  = -
28.00*^ 
 =  
0.00^ 
abstinent 
 = -6.00  = 2.33  = 1.00  = -7.00  = +0.19 






Appendix B: Self-Compassion 5-Session Treatment Guide 
 
Session 1: Mindfulness  
 
General Information (10 minutes) 
- Introduce mindfulness as a concept (e.g., knowing what you are experiencing it while you 
are experiencing it, moment to moment awareness without judgment).  
- One can increase mindfulness with practice. 
- You don’t have to be calm to be mindful, just need to be aware. 
 
“Mindfulness of Breathing” Exercise (30 minutes total) 
- Complete the exercise 
- Activity Discussion- what was it like? What was difficult? How did you feel while 
 doing it? (15 minutes) 
 
 
Mindfulness at Home/In The Real World Discussion (15 minutes) 
- Mindful walking 
- Mindful breathing 
 
HOMEWORK: Do a mindfulness activity for 20 minutes, two times this week (e.g., focus on 







Session 2: Emotional Acceptance  
 
General Information (15 minutes) 
- Labeling Emotions: This helps free our brain up. They are “just emotions;” not as scary.  
o More than just noticing 
o Make sure labels are kind and compassionate 
o Talk about how to label emotions and practice together 
 
“Labeling Emotions” Exercise (30 minutes) 
Bring awareness to body, hand on heart, mindful awareness of breathing, 5 
minutes. Release breath, keeping attention to heart region. What am I 
feeling? Let attn be drawn to strongest emotion. Give strongest feeling a 
name. At first you might feel “contentment” or “curious” but let the other 
emotions come to you also. Repeat the label two, three times in a kind, 
gentle voice to yourself, return to breath. Go back and forth between breath 
and emotions in relaxed way. Don’t force an emotion. If you feel 
overwhelmed, stay with breath until feel better. (15 minutes) 
 
Discuss what it was like to sit with emotions and label them. (15 minutes) 
 
Homework: When feelings stressed/worried/angry etc., take 20 minutes to notice and 
 label emotions. Sit with them, and write down any thoughts/feelings to share with the 







Session 3: Difficult Emotions 
 
General Information (10 minutes) 
- Steps to Accepting and Moving on From Negative Emotions  
o Aversion: resistance, avoidance, rumination 
o Curiosity: turning toward discomfort with interest 
o Tolerance: safely enduring pain 
- Benefits of Negative Emotions: they provide important information for us.  
- Cycle of Negative Emotions 
o Emotions get stronger when we fight them 
o I don’t like this feeling  I wish I didn’t have this feeling  I shouldn’t have this 
feeling  I’m wrong to have this feelings  I’m bad.  
 
“Mindfulness of Emotion in Body” and “Soften, Allow & Love” Exercise (35 minutes) 
”Mindfulness of Emotion in Body:” Need to locate emotions first and be 
aware of them. Think of a difficult emotion that you’re feeling. If you 
aren’t currently feeling anything difficult, think of one that commonly 
occurs. Feel your body, bring attention to heart region, put hand on heart, 
find breath in heart region and feel chest move as you breathe. After few 
minutes, release attn to breath let yourself recall the difficult emotion, 
remember situation when you’ve felt it/brought it on. Now expand 
awareness to body as a whole, where do you feel it most? Sweep body head 
to toe. Choose single location in body feeling most. Incline to that spot, 
breathe naturally, allow gentle rhythmic motion of breath to soothe body. If 
you feel overwhelmed, stay with breath until feel better and then return to 
emotion.  
 
“Soften Allow and Love”:  Soften to location in body, let muscles be soft 
without requiring they be soft, allow discomfort to be there, abandon wish 
for feeling to disappear, love yourself for suffering this way, hand over 
heart and breathe, direct love at part of body under stress, think of body as 
beloved child. Soften, allow, love, mantra. 
 
Discuss what it was like to give comfort toward self while feeling 
something negative. 
 







Session 4: Caring for Ourselves: Self-Kindness 
 
5 Pathways to Self-Compassion Handout! (20 minutes) 
- Physically  
o Softening into your body when under stress. Nap, eat nourishing food, take 10 
minutes in the sun, exercise, talk to medical doctor.  
o How can each of you care for yourselves physically? 
- Mentally 
o Allowing your thoughts to come and go, stop resisting. 
o Mantras: “this too will pass” or “one day at a time.” 
o Put things into perspective 
o Come up with Mantras together 
- Emotionally 
o Befriend painful emotions and stop fighting them. Be kind toward ourselves. 
o Treat ourselves to enjoyable activities (listen to music, go for a walk, read, eat 
your favorite meal). 
- Relationally 
o Connect with others. Don’t isolate; it makes us more uncomfortable. Be helpful to 
others. 
- Spiritually 
o Our values, God, etc. 
o Take the time to cultivate the values that we hold dear. If we don’t attend to our 
values, we’ll absorb the values of our consumer culture.  
 
Cultivating Positive Emotions (10 minutes) 
- Positive emotions 1) feel good and 2) reach beyond the individual 
Examples: affection, cheerfulness, hope, surprise.  
a. Read story (Germer 2009, pp 120) “feeding the emotion you want to win-
out” 
 
“Loving Kindness Meditation” (15 minutes) 
b. Sit down, close eyes, bring attention to heart region. Slow easy breaths. 
Form image of self sitting down, as if seeing yourself from the outside. 
Recall that every living being wants to live peacefully and happily, “Just as 
all beings wish to be happy and free from suffering, may I be happy and 
free from suffering.” Let self feel warmth of loving intention. Repeat 
phrases silently: “May I be safe. May I be happy. May I be healthy. May I 
live with ease.” Let each phrase mean what it says. Take time.  
 
HOMEWORK: Repeat the phrases of love to yourself during times of stress/difficulty. 







Session 5: Common Humanity: Staying Connected to Others 
 
General Information (15 minutes) 
- Importance of a support network 
- It can be hard to “let people in.” Why? Share positive experiences of letting others in. 
- What happens when we feel isolated? Cravings? Sadness? Frustration?  
- The power of compassion for physical and mental health.  
 
Metta Meditations for Self and Others (20 minutes) 
Can be done walking or sitting. Sit still for a moment, anchor your 
attention in your body. Recall that every living being wants to live 
happily and peacefully. “Just as all beings wish to be happy and free 
from suffering, may I be happy and free from suffering.” Feel the 
sensations of your body. “safe, happy, healthy, ease.” When mind 
wanders, return to phrases. Halfway through, send it to others: “May 
you and I be safe. May you and I be happy. May you and I be healthy. 
May you and I live with ease.” Include everything and everyone in 
this group. Others with similar or different struggles. End with: “May 
all things be happy and free from suffering.” 
 
Loving Others without Losing Yourself (15 minutes) 
- How to offer help to others in ways that feels good 
- How to stay connected and not lose yourself in the process 
- How to know when you need to care for yourself?
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